Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advised Orexo on private placement
Mandate

Vinge advised Orexo on private placement

September 08, 2014

Orexo AB (publ) (NASDAQ OMX Stockholm) has completed a private placement of Orexo shares to qualified investors, resulting in total cash proceeds of approximately SEK 346.5 million before transaction costs.

Vinge acted as legal adviser to Orexo. The Vinge team included Erik Sjöman (partner, capital markets and public M&A) and associates Christian Lindhé, Rikard Lindahl and Madelene Eriksson.

 

 

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

 Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

 Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025